1-6 of 6
Ihab El-Hemaidi
Close
Sort by
Journal Articles

Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City - Jeddah - KSA Experience

Muteb Althomali, Ahmad Absi, Ihab El Hemaidi, Ashraf Warsi, Sameer AlAmoudi, Majed Alahmadi, Walaa Rajkhan, Sultan Almutairi, Saleem Eldadah, Manar Khalil, Muna Adam, Syed Adnaan Ali, Abdulrahman Alghamdi, Ahmad Alsaeed
Journal: Blood
Blood (2019) 134 (Supplement_1): 5295.
https://doi.org/10.1182/blood-2019-121993
Published: 2019
Journal Articles

Long Term Outcomes Of Imatinib In Chronic Myeloid Leukemia In Saudi Population, Single Center Study

Enaam Mohammed Alsobhi, MD FRCPath, Mohammed m Abrar, Phd, Mohammed A Abdelaal, MD FRCPath, Ahmad S. Alsaeed, MD, Ahmed Al-Absi, MD, Zaid A Zahrani, MD, Ashraf A Warsi, MD, Abdulfattah Al-Amri, PhD, Ihab El-Hemaidi, MBBS, MRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 5180.
https://doi.org/10.1182/blood.V122.21.5180.5180
Published: 2013
Journal Articles

Outcome and Toxicities of Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy Used in the Treatment of Acute Lymphoblastic Leukemia in Adolescent and Young Adult Patients, Single Center Experience From Saudi Arabia

Suhaib Radi, MBBS, Anas Merdad, MBBS, Mona Al-Dabbagh, MD MHSc, Ahmed Almohanad Absi, MD, FACP, Ahmad Alsaeed, MD, Ihab El-Hemaidi, MBBS, MRCP, FRCPath
Journal: Blood
Blood (2012) 120 (21): 3569.
https://doi.org/10.1182/blood.V120.21.3569.3569
Published: 2012
Journal Articles

Clonal Gammopathies, Immune Cytopenias and Autoimmune Thyroid Dysfunction Following Alemtuzumab Containing Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Mojtaba Akhtari, Kavita Raj, Wendy Ingram, Dragana Milojkovic, Ihab El-Hemaidi, Stephen Devereux, Antonio Pagliuca, Aloysius Ho, Ghulam Mufti
Journal: Blood
Blood (2004) 104 (11): 1839.
https://doi.org/10.1182/blood.V104.11.1839.1839
Published: 2004
Journal Articles

Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200

Aloysius Y. L. Ho, Michelle Kenyon, Ihab El-Hemaidi, Stephen Devereux, Antonio Pagliuca, Ghulam J. Mufti
Journal: Blood
Blood (2003) 101 (2): 779–780.
https://doi.org/10.1182/blood-2002-07-2256
Published: 2003
Journal Articles

Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera

Brief Report
Ayalew Tefferi, Michelle A. Elliott, Pai Chih Kao, Sooyoung Yoon, Ihab El-Hemaidi, Thomas C. Pearson
Journal: Blood
Blood (2000) 96 (4): 1582–1584.
https://doi.org/10.1182/blood.V96.4.1582
Published: 2000